231
Participants
Start Date
September 27, 2012
Primary Completion Date
March 8, 2017
Study Completion Date
February 7, 2019
Obinutuzumab
Obinutuzumab 1000 mg will be administered by IV infusion on Days 1, 8, 15 of first 21-Day cycle and on Day 1 of subsequent 21-day cycles for up to 8 cycles.
Pinatuzumab Vedotin
Pinatuzumab Vedotin 1.8 or 2.4 mg/kg administered by IV infusion on Day 1 or 2 of every 21-day cycle.
Polatuzumab Vedotin
Polatuzumab Vedotin 1.8 or 2.4 mg/kg administered by IV infusion on Day 1 or 2 of every 21-day cycle.
Rituximab
RTX 375 mg/m\^2 administered by IV infusion on Day 1 of every 21-day cycle.
New York University Cancer Cen, New York
Azienda Ospedale San Giovanni, Turin
Roswell Park Cancer Inst., Buffalo
Georgetown University Medical Center Lombardi Cancer Center, Washington D.C.
Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2, Milan
Fairfax N Virginia Hem/Onc PC, Fairfax
Oncology & Hematolgy Associates of SW Va Inc. - Roanoke, Roanoke
Florida Cancer Specialists - Fort Myers (Colonial Center Dr), Fort Myers
Florida Cancer Specialists; Sarasota, Sarasota
CHU Montpellier - Saint ELOI, Montpellier
Sarah Cannon Cancer Center - Tennessee Oncology, Pllc, Nashville
A.O. Universitaria Policlinico S.Orsola-Malpighi Di Bologna, Bologna
Oncology Hematology Care Inc, Cincinnati
Univ of Michigan Med School; Hematology Oncology, Ann Arbor
Univ of Wisconsin-Madison, Madison
Universitätsmedizin Johannes Gutenberg Universität; Klinik u. Poliklinik f. Neurologie, Mainz
Hopital Claude Huriez - CHU Lille, Lille
Uniklinik Heidelberg, Medizinische Klinik & Poliklinik V, Heidelberg
Centre Hospitalier Lyon Sud, Pierre-Bénite
Texas Oncology-Baylor Sammons Cancer Center, Dallas
Hopital Saint Louis ; Service d Oncologie Medicale Fougere 6 (Pr Misset), Paris
Texas Oncology, P.A. - Tyler; Tyler Cancer Center, Tyler
Centre Henri Becquerel; Hematologie, Rouen
Cancer Care Centers of South Texas, San Antonio
Texas Transplant Inst., San Antonio
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center, Denver
Klinikum d.Universität München Campus Großhadern, München
Comprehensive Cancer Centers of Nevada - Eastern Avenue, Las Vegas
Cedars-Sinai Medical Center, Los Angeles
Oregon Health Sciences Uni, Portland
Fred Hutchinson Cancer Research Center, Seattle
Northwest Cancer Specialists - Vancouver, Vancouver
Yakima Valley Memorial Hospital/North Star Lodge, Yakima
Stanford Cancer Center, Stanford
Hematology Oncology Associates; Carol G. Simon Ctr, Morristown
Regional Cancer Care Associates LLC - Morristown, Morristown
Willamette Valley Cancer Ctr - 520 Country Club, Eugene
Cross Cancer Institute, Edmonton
British Columbia Cancer Agency, Vancouver
McGill University; Sir Mortimer B Davis Jewish General Hospital; Oncology, Montreal
Academisch Medisch Centrum; Hematologie, Amsterdam
Lead Sponsor
Genentech, Inc.
INDUSTRY